ClinVar Miner

Submissions for variant NM_001370658.1(BTD):c.1569C>A (p.Asp523Glu)

gnomAD frequency: 0.00024  dbSNP: rs146136265
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 9
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000078071 SCV000109909 pathogenic not provided 2018-01-03 criteria provided, single submitter clinical testing
Invitae RCV000022028 SCV000630332 pathogenic Biotinidase deficiency 2024-01-19 criteria provided, single submitter clinical testing This sequence change replaces aspartic acid, which is acidic and polar, with glutamic acid, which is acidic and polar, at codon 543 of the BTD protein (p.Asp543Glu). This variant is present in population databases (rs146136265, gnomAD 0.06%). This missense change has been observed in individual(s) with biotinidase deficiency (PMID: 25174816, 25967232, 28498829). ClinVar contains an entry for this variant (Variation ID: 25103). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BTD protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic.
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000078071 SCV000888013 pathogenic not provided 2018-08-24 criteria provided, single submitter clinical testing
Mendelics RCV000022028 SCV001136351 pathogenic Biotinidase deficiency 2019-05-28 criteria provided, single submitter clinical testing
Baylor Genetics RCV000022028 SCV003835260 pathogenic Biotinidase deficiency 2022-08-20 criteria provided, single submitter clinical testing
GeneDx RCV000078071 SCV004039642 likely pathogenic not provided 2023-09-26 criteria provided, single submitter clinical testing In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also known as D543E; This variant is associated with the following publications: (PMID: 25967232, 26810761, 25174816, 22698809, 28498829, 35167647, 31801038)
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein RCV000022028 SCV004183396 likely pathogenic Biotinidase deficiency 2020-03-03 criteria provided, single submitter clinical testing ACMG classification criteria: PS4, PM2, PM3, PP2
Counsyl RCV000022028 SCV000798766 likely pathogenic Biotinidase deficiency 2018-03-30 no assertion criteria provided clinical testing
Natera, Inc. RCV000022028 SCV001461231 pathogenic Biotinidase deficiency 2020-09-16 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.